🇬🇧 United Kingdom Country × Condition
haematological malignancy Clinical Trials in United Kingdom
Active clinical trials for haematological malignancy with research sites in United Kingdom. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇬🇧 United Kingdom
Active Trials in United Kingdom (3)
NCT05770037 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
Enrollment
30 pts
Country
🇬🇧 United Kingdom
Cancer Research UK
View Trial → NCT05722886 Phase 2, Phase 3
Recruiting
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol
Enrollment
825 pts
Country
🇬🇧 United Kingdom
Cancer Research UK
View Trial → NCT05786716 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
Enrollment
30 pts
Country
🇬🇧 United Kingdom
Cancer Research UK
View Trial → Frequently Asked Questions
How many haematological malignancy clinical trials are active in United Kingdom?
There are currently 3 active clinical trials for haematological malignancy with sites in United Kingdom, of which 3 are actively recruiting patients.
How can I join a haematological malignancy clinical trial in United Kingdom?
To join a haematological malignancy clinical trial in United Kingdom, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United Kingdom directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are haematological malignancy trials in United Kingdom?
Active haematological malignancy trials in United Kingdom span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology